Cohort1: Unvaccinated
|
Administration route |
None |
Pts |
10880 |
Age |
Adult, Older_Adult |
Adverse reactions |
384/10880(All-cause mortality); 4176/10880(Cardiac disorders; Renal and urinary disorders; Respiratory, thoracic and mediastinal disorders) |
|
Cohort2: Partially vaccinated
|
Administration route |
None |
Pts |
825 |
Age |
Adult, Older_Adult |
Adverse reactions |
50/825(All-cause mortality); 410/825(Cardiac disorders; Renal and urinary disorders; Respiratory, thoracic and mediastinal disorders) |
|
Cohort3: Fully vaccinated
|
Administration route |
None |
Pts |
129 |
Age |
Adult, Older_Adult |
Adverse reactions |
8/129(All-cause mortality); 64/129(Cardiac disorders; Respiratory, thoracic and mediastinal disorders) |
|